GLP-1 Medication Side Effects Frequency Database, 2026

Ozari Health published a structured database of adverse event frequency data for GLP-1 weight loss medications in May 2026. It contains 40 adverse events across 5 medications, sourced from published Phase 3 clinical trials and FDA prescribing information.

Use Cases

• Compare side effect frequencies between different GLP-1 medications based on the structured adverse event data.
• Analyze the safety profile of weight loss drugs based on clinical trial and FDA prescribing information.
• Validate or supplement pharmacovigilance studies using aggregated adverse event data from Phase 3 trials.

Strengths

• Data is sourced from authoritative clinical trial and FDA prescribing documents.
• Covers 40 distinct adverse events across 5 specific medications.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Ozari Health

Collection Method

Aggregated from published Phase 3 clinical trials and FDA prescribing information.

Freshness

Last updated 2026-05-18 00:06:44